To assess the anti-obesity efficacy of chronic AMPK activation in vivo, we investigated the effect of the administration of A-769662, an AMPK allosteric activator, in chow- and HFD-fed mice. The gene discussed is PRKAA2; the disease is obesity due to melanocortin 4 receptor deficiency.